Wang Chendong, Hang Yu, Cao Yuezhou, Zhao Linbo, Jiao Jincheng, Li Mingfang, Xu Xiaoquan, Jiang Lei, Liu Sheng, Shi Haibin, Jia Zhenyu
Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Rd, Nanjing, 210029, China.
Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Rd, Nanjing, 210029, China.
J Stroke Cerebrovasc Dis. 2022 Apr;31(4):106347. doi: 10.1016/j.jstrokecerebrovasdis.2022.106347. Epub 2022 Feb 12.
Anticoagulation (AC) is the main preventive strategy for ischemic stroke in atrial fibrillation (AF) patients. We aim to investigate the association of prior AC with thrombus composition and clinical outcome in AF patients with acute ischemic stroke (AIS).
From January 2019 to December 2020, consecutive AIS patients with AF treated with mechanical thrombectomy (MT) in our center were included in this analysis. Retrieved thrombi were stained with hematoxylin and eosin (H&E) and Martius Scarlet blue (MSB). The relative fractions of red blood cell (RBC), white blood cell (WBC), fibrin, and platelet were quantitatively analyzed. Procedural and clinical outcomes were compared between patients with and without prior AC.
A total of 133 patients were enrolled in this study, with 39 in AC group and 94 in non-AC (NAC) group. Thrombi in AC group contained more fibrins (36% vs 20%, p<0.001), more platelets (36% vs 24%, p<0.001) and fewer RBCs (25% vs 54%, p<0.001). No difference was detected in terms of successful recanalization evaluated with modified Thrombolysis in Cerebral Infarction scale (mTICI 2b-3, 97% vs 86%, p=0.065), functional independence at 90 days with modified Rankin Score (mRS 0-2, 44% vs 33%, p=0.246).
Thrombi retrieved from AF patients with prior AC contained more fibrins, more platelets and fewer RBCs compared with those of NAC patients. A trend of higher successful reperfusion rate was observed in AC patients but failed to reach statistical significance.
抗凝治疗(AC)是心房颤动(AF)患者缺血性卒中的主要预防策略。我们旨在研究既往抗凝治疗与急性缺血性卒中(AIS)合并AF患者血栓成分及临床结局之间的关联。
纳入2019年1月至2020年12月在本中心接受机械取栓(MT)治疗的连续性AIS合并AF患者进行分析。取出的血栓用苏木精-伊红(H&E)和马休黄猩红蓝(MSB)染色。对红细胞(RBC)、白细胞(WBC)、纤维蛋白和血小板的相对比例进行定量分析。比较有或无既往抗凝治疗患者的手术及临床结局。
本研究共纳入133例患者,抗凝组39例,非抗凝(NAC)组94例。抗凝组血栓中纤维蛋白更多(36%对20%,p<0.001),血小板更多(36%对24%,p<0.001),红细胞更少(25%对54%,p<0.001)。在采用改良脑梗死溶栓量表(mTICI 2b-3)评估的成功再通方面(97%对86%,p=0.065)以及采用改良Rankin量表(mRS 0-2)评估的90天时功能独立性方面(44%对33%,p=0.246),未检测到差异。
与NAC组患者相比,既往接受抗凝治疗的AF患者取出的血栓中纤维蛋白更多、血小板更多、红细胞更少。抗凝组患者有更高成功再灌注率的趋势,但未达到统计学意义。